Your browser doesn't support javascript.
loading
NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells.
Moon, Du G; Lee, Sang E; Oh, Mi M; Lee, Sang C; Jeong, Seong J; Hong, Sung K; Yoon, Cheol Y; Byun, Seok S; Park, Hong S; Cheon, Jun.
Afiliação
  • Moon du G; Department of Urology, College of Medicine, Korea University, Guro Hospital, Seoul, Republic of Korea.
  • Lee SE; Department of Urology, School of Medicine, Seoul National University, Bundang Hospital, Gyeonggi­do, Seoul, Republic of Korea.
  • Oh MM; Department of Urology, College of Medicine, Korea University, Guro Hospital, Seoul, Republic of Korea.
  • Lee SC; Department of Urology, School of Medicine, Seoul National University, Bundang Hospital, Gyeonggi­do, Seoul, Republic of Korea.
  • Jeong SJ; Department of Urology, School of Medicine, Seoul National University, Bundang Hospital, Gyeonggi­do, Seoul, Republic of Korea.
  • Hong SK; Department of Urology, School of Medicine, Seoul National University, Bundang Hospital, Gyeonggi­do, Seoul, Republic of Korea.
  • Yoon CY; Department of Urology, College of Medicine, Korea University, Guro Hospital, Seoul, Republic of Korea.
  • Byun SS; Department of Urology, School of Medicine, Seoul National University, Bundang Hospital, Gyeonggi­do, Seoul, Republic of Korea.
  • Park HS; Department of Urology, College of Medicine, Korea University, Guro Hospital, Seoul, Republic of Korea.
  • Cheon J; Department of Urology, College of Medicine, Korea University, Anam Hospital, Seoul, Republic of Korea.
Int J Oncol ; 45(3): 1027-35, 2014 Sep.
Article em En | MEDLINE | ID: mdl-24969552

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Bexiga Urinária / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Imidazóis / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Bexiga Urinária / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Imidazóis / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article